Mycobacterium smegmatis inactivates rifampin by ribosylating this antibiotic. The gene responsible for this ability was cloned and was shown to confer low-level resistance to this antibiotic (MIC increase, about 12-fold) in related organisms. A 600-bp subclone responsible for ribosylating activity and resistance carried an open reading frame of 429 bp. Targeted disruption of the gene in M. smegmatis resulted in mutants with much increased susceptibility to rifampin (MICs of 1.5 instead of 20 g/ml) as well as the loss of antibioticinactivating ability. Also, disruption of this gene led to a much lower frequency of occurrence of spontaneous high-level rifampin-resistant mutants.
Rifampin is a major chemotherapeutic agent used to treat infections caused by strains of Mycobacterium (16) and the closely related genera Nocardia, Gordona, and Rhodococcus (9, 15) . A component of the response to this antibiotic involves inactivation processes. Four mechanisms have been identified: decomposition (4, 10, 37) , phosphorylation (37) , glucosylation (36) , and ribosylation (12) . The mechanisms differ depending on the genus: ribosylation in Mycobacterium and the closely related genera Gordona and Tsukamurella, phosphorylation in the genera Nocardia and Rhodococcus, and glucosylation in the genus Nocardia (32) . Decomposition is most widespread, being found in Nocardia, Rhodococcus, and Mycobacterium (4, 32, 37) . We recently cloned the rifampin decomposition gene from Rhodococcus equi and found the sequence to strongly resemble those encoding monooxygenases acting upon phenolic compounds, consistent with the presence of a naphthalenyl moiety in the rifampin molecule (24) . Clinical strains of Corynebacterium, Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa were unable to inactivate rifampin (13) . Bacillus species are the only other hitherto identified bacteria which are able to inactivate this antibiotic (13) .
Rifampin resistance is increasing in clinical isolates. In Mycobacterium tuberculosis and Mycobacterium leprae high-level resistance is nearly always the result of mutational alteration of the target molecule, the ␤ subunit of RNA polymerase (20, 33) . However, most rifampin-resistant clinical isolates of Mycobacterium avium and Mycobacterium intracellulare strains did not have any mutations in the rpoB gene (18) . Hetherington et al. (19) showed that Mycobacterium smegmatis, which is naturally resistant to the antibiotic, had no identifiable rpoB mutations and suggested that another mechanism of resistance might be present. Strains of M. tuberculosis displaying low to intermediate levels of resistance in many cases have no alterations in this protein (24a, 26); Ohno et al. (27) detected mutations in the rpoB genes of only half of M. tuberculosis isolates with intermediate resistance levels. These observations suggested the existence of other genes able to confer a degree of resistance; Hui et al. (21) and Abadi et al. (1) provided evidence that changes in cell wall permeability might diminish rifampin susceptibility. Inactivating enzyme genes are another candidate.
This work was undertaken to clone and characterize a gene(s) from M. smegmatis and investigate its involvement in the rifampin resistance of this organism by gene disruption techniques. The inactivation mechanism in this strain, for which the MIC is 20 g/ml, has been shown to be ribosylation (12, 32) . The characterization of the gene responsible is additionally of interest since this is the only instance of antibiotic inactivation by the addition of ribose identified so far.
MATERIALS AND METHODS
Bacterial strains and plasmids. The bacterial strains and plasmids used in this study are listed in Table 1 . M. smegmatis was grown in 3% brain heart infusion (BHI) medium (Difco) at 37°C. E. coli and Rhodococcus rhodochrous were grown in Luria-Bertani medium (1% tryptone, 0.5% yeast extract, 0.5% sodium chloride) at 37 and 28°C, respectively. Plasmids were selected for and maintained in E. coli by the addition of ampicillin at 100 g/ml; in nocardioform strains they were selected by using 40 g of chloramphenicol per ml and were maintained by using 20 g of this antibiotic per ml. Vector pDA71 has a positive selection function due to the EcoR endonuclease with expression turned off by the bacteriophage repressor so it is maintained in a lysogen of E. coli.
Transformations. In E. coli transformation was performed by the CaCl 2 method (29) . Transformations into rhodococci were performed by using polyethylene glycol-generated protoplasts (11, 28) or by electroporation, as described previously (23) . M. smegmatis was transformed by electroporation, with the conditions being as described above except that the voltage was 2.5 kV and resistance was 1,000 ⍀; 1 ml of BHI broth was then added to the cells, which were incubated at 37°C for 3 h and then spread onto BHI plates supplemented with 20 g of kanamycin per ml.
DNA manipulation. The restriction endonucleases and other enzymes used in DNA manipulations were obtained from Boehringer Mannheim (Mannheim, Germany), Amersham (Buckinghamshire, England), or New England Biolabs (Beverly, Mass.) and were used according to the manufacturers' instructions. All restriction mapping was done with DNA from E. coli GM2929 dam dcm (Table  1) . Chromosomal and plasmid DNAs were purified by cesium chloride gradient centrifugation as described previously (11, 28) . DNA fragments were purified after electrophoresis through low-gelling-temperature agarose (SeaPlaque); after excision the agarose was melted at 65°C, extracted twice with TE-saturated phenol and once with chloroform, precipitated, and dried. Sequencing of singlestranded DNA was performed with M13mp18 and M13mp19 with the Sequenase, version 2.0, kit (United States Biochemicals). To eliminate compressions arising from the high GϩC content of this DNA, the nucleotide dITP instead of dGTP was used (6, 17) , with dimethyl sulfoxide used in the reaction mixtures (30, 31) .
Southern blot assays. Southern blot assays were performed with a digoxigeninbased nonradioactive kit from Boehringer Mannheim. About 5 g of appropriately digested genomic DNA was run on a 0.8% agarose gel, blotted onto Hybond N paper (Amersham), and probed with about 500 ng of the SalI fragment of mycobacterial DNA. The blot was washed twice for 5 min each time at room temperature with 2ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate) and then twice for 15 min each time at 68°C with 0.1ϫ SSC-0.1% sodium dodecyl sulfate.
Rifampin inactivation and susceptibility. Absorbance measurements of rifampin solutions were made with Milton Roy Spectronic Genesys 5 UV-VIS spectrophotometer. Rifampin concentrations were assayed by using Bacillus subtilis 1A3-1, as described before (10) . Inactivation was monitored by measuring the zones of inhibition on plates spread with a lawn of this bacterium; decolorization was monitored spectrophotometrically. The rifampin MIC was found by spotting with a replicator about 10 4 CFU on plates with a range of antibiotic concentrations; the highest concentration at which there was confluent growth was taken as the resistance level.
Thin-layer chromatography. For thin-layer chromatography analysis, samples of inactivated rifampin were extracted from cultures with 0.2 volume of ethyl acetate after the bacteria had been removed by centrifugation and the pH of the supernatant had been adjusted to between 2.0 and 3.0 with HCl. The dried pellet was extracted with 10 l of acetone to dissolve the antibiotic, and then this was run on a silica gel plate (Merck 60F 254 ) with chloroform-methanol (8:2) as the solvent.
Nucleotide sequence accession number. The sequence presented in Fig. 2 has been assigned GenBank accession no. AF001493.
RESULTS AND DISCUSSION
Selection of M. smegmatis rifampin inactivation gene. Chromosomal DNA from M. smegmatis DSM 43756 was used to construct a genomic library in shuttle vector pDA71, which is stably maintained in E. coli and several strains of Rhodococcus (14, 28) . Both plasmid and genomic DNAs were digested with BglII, and a library of about 12,900 clones was obtained in E. coli MM294-4. The average insert size was 9.3 kb. The pool of clones was transformed into R. rhodochrous CW25, which lacks the ability to inactivate rifampin and which is highly susceptible to this antibiotic (4): it is inhibited by 50 ng of rifampin per ml. Clones conferring increased levels of resistance were recovered by spreading the transformants on plates supplemented with 300 ng of rifampin per ml, since it was expected that the ability to inactivate this compound would confer a phenotype of increased resistance, as we observed for a monooxygenase clone from R. equi (4) .
Clones which grew on selective plates had plasmids which fell into three groups on the basis of restriction enzyme digestions. Only one of the three groups conferred rifampin-inactivating ability on strain CW25, in addition to reduced susceptibility. The DNA insert in pDA71 was 7.3 kb and comprised two BglII fragments; retransformed into strain CW25, this DNA conferred about a 12-fold increased rifampin MIC for the strain. Preliminary subcloning experiments indicated that the larger of the two fragments, about 4 kb, was responsible for both increased levels of rifampin resistance and inactivation: the CW25 strain bearing this DNA completely inactivated 20 g of this compound per ml in about 20 h (Fig. 1A) , as monitored by measuring the zones of inhibition on plates spread with a test strain of B. subtilis. No absorbance spectrum changes concomitant with inactivation were detected, in contrast to the decolorization observed with the previously characterized R. equi rifampin inactivation clone (4) . Also, in contrast to the latter, an inactivated product could be recovered: it was extracted with ethyl acetate from culture supernatants of CW25 carrying this M. smegmatis DNA. Chromatography on silica gels with chloroform-methanol extracts showed two spots not present in controls, with R f values indistinguishable from those of the M. smegmatis strain that inactivated rifampin itself (12) . These two moieties have been shown to be ribosylated rifampin and ribosylated 3-formyl-rifamycin SV (12) , with the latter arising by hydrolytic removal of the piperidine side chain from rifampin. This removal has also been observed in phosphorylative or glucosylative inactivations with either nocardioform strains (36, 37) or Bacillus species (13) . These studies found that it was not an artifact of preparation techniques; it is not the cause of the inactivation, and the reason for its occurrence is unclear.
Effect of Tween 80. The rifampin ribosylating clone inactivated antibiotic about five times more slowly than the other inactivating clone hitherto identified, viz., the R. equi rifampin decomposition clone (Fig. 1A) . Several reports (34, 35) have highlighted the effects of Tween 80 on the susceptibility of mycobacteria to many antibiotics, including rifampin. It was postulated that the detergent action of this compound affected the permeability of the cell walls of these organisms, facilitating passage of antibiotic into the cell (21, 25, 35) . We investigated the influence of Tween 80 (0.5%, a nonretarding concentration) on the mycobacterial clone. The ability to inactivate rifampin was greatly inhibited, although the growth of the strain was not otherwise impaired. In contrast, the rhodococcal rifampin-inactivating clone inactivated the antibiotic at a similar rate, irrespective of the presence or absence of this detergent (Fig. 1B) . These results suggested that one reason for the increased susceptibility of mycobacterial strains to rifampin in the presence of Tween 80 might be interference with an endogenous capacity to inactivate this antibiotic.
Gene sequence. Subcloning of the 4-kb BglII segment revealed that a 1.1-kb SalI fragment within it carried all the information for reduced rifampin susceptibility and antibiotic inactivation ability. Subclones of the SalI DNA were ligated to M13mp18 or M13mp19 and the sequence was determined. The DNA was 1,183 bp in length (Fig. 2) with a GϩC content of 63%. Codon usage analysis with the FRAME program (7) identified a region from nucleotides 340 to 800 with a high codon bias. There were no potential ATG start codons in this region, but two successive GTG codons started at position 356; in mycobacteria, GTG start codons are common and an analysis of the TRANSTERM database (8) which collates transcriptional start and stop signals confirmed this: in M. smegmatis 18 of 44 strains (41%) used GTG as start codon; the proportions for M. leprae and M. tuberculosis were 52% (n ϭ A search for homologous sequences in GenBank was performed with the local alignment algorithm BLASTN (3), with the entire sequence of the SalI fragment used as input. The best match [P(N) ϭ 0.0073] was with DNA for the R. equi iri gene responsible for rifampin inactivation by hydroxylation; the region resulting in this high-segment-pair score was located within the putative upstream regulatory regions of both sequences, which may indicate a common regulation of expression for both genes.
Inactivation of gene by homologous recombination. To test whether this gene was responsible for rifampin resistance or inactivation in M. smegmatis DSM 43756, the gene was disrupted by homologous recombination. Previous work with M. smegmatis has demonstrated that the Tn903 kanamycin resistance gene (aph) is functional and can be used as a selectable marker (22) . To create a construct with the inactivated gene, the 1.3-kb kanamycin resistance cassette was removed from pUC4K by AccI digestion and was ligated into the SfuI site of the mycobacterial SalI segment carried by pGEM3Zf(Ϫ) in the opposite transcriptional orientation. This plasmid is unable to replicate in M. smegmatis. Tests confirmed that this manipulation abolished the rifampin resistance of the cloned gene.
Reports indicate that linearized DNA is more recombinogenic than circular DNA in Mycobacterium (2, 5) , so the linearized construct was electroporated into strain DSM 43756, selecting for kanamycin resistance. Southern blots were made by using SalI-digested genomic DNAs from transformants selected in this way by probing with the 1.1-kb SalI fragment. Six of the seven transformants tested still showed a 1.1-kb hybridizing band (including 43756Km4, which was used as a control in further experiments), whereas one (transformant 43756Km1) showed a hybridizing band of 2.3 kb, the expected size of the SalI fragment containing the kanamycin resistance gene. Additionally, an internal 0.56-kb SfuI-XhoI fragment of the mycobacterial gene was used as a probe and gave a similar result. This 0.56-kb fragment was then used to probe the genomic DNA of transformant 43756Km1 digested with either PstI or BamHI. The kanamycin resistance cassette is removed by PstI digestion, and a decrease in the size of the hybridizing band was expected, whereas neither the mycobacterial gene nor the kanamycin resistance gene is cut by BamHI, and in this case an increase in the size of the hybridizing band compared with the size of the hybridizing band of the parental strain was expected. This was confirmed by the results.
Phenotype of 43756Km1. The rifampin phenotype of transformant 43756Km1 was compared with that of strain DSM 43756 and with those of other kanamycin-resistant transformants such as 43756Km4. It showed greatly increased susceptibility to this antibiotic (MIC, about 1.5 g/ml for 43756Km1 compared with MICs of 20 g/ml for the other strains). The other transformants did not show increased susceptibility. Other changes in phenotype were not detectable for mutant 43756Km1: its morphology and pigmentation were indistinguishable from those of the parent. By using a range of concentrations, a comparison of rifampin inactivation, as monitored by measuring zones of inhibition, demonstrated that 43756Km1 had a greatly diminished inactivation capacity compared with that of its parent (Fig. 3) . Therefore, in M. smegma- tis the rifampin inactivation by ribosylation is a major contriutor to this strain's low level of susceptibility to the antibiotic.
Frequency of rifampin resistance in gene-disrupted mutant. To test whether the presence of the ribosylation gene influenced the frequency of generation of spontaneous high-level rifampin resistance mutants, these were selected on BHI agar supplemented with 100 g of antibiotic per ml. The mutation rates for parental strain DSM 43756 and mutants 43756Km1 and 43756Km4 were 1.0 ϫ 10 Ϫ6 , 2.9 ϫ 10 Ϫ8 , and 3.2 ϫ 10 Ϫ6 , respectively. Thus, in this experiment the frequencies of occurrence of mutants of 43756Km1 that were resistant to 100 g of rifampin per ml were between 35-and 110-fold lower than those for the other strains. Additional selections on BHI medium supplemented with Ͼ100 g of rifampin per ml consistently showed more than 100-fold lower mutation rates for the mutant which was unable to inactivate this compound. These results demonstrate that in M. smegmatis the presence of the rifampin ribosylating gene has a major influence on the frequency with which mutants with high levels of resistance are generated.
We have shown that the ribosylative inactivation of rifampin is a major contributor to the low level of susceptibility of M. smegmatis DSM 43756. Most species of Mycobacterium, as well as species of the closely related genera Gordona and Tsukamurella, have been shown to inactivate rifampin by ribosylation (32), so the findings described here may be relevant to these organisms also. We used DNA carrying the cloned gene to perform Southern blots with genomic DNA from these related organisms (data not shown); one or more hybridizing bands were detected, but the signal was weak, suggesting that the sequence of the corresponding gene is not highly conserved.
The strong similarities of the DNA sequences upstream of the genes responsible for inactivating rifampin by ribosylation or hydroxylation suggest a common pattern of regulation for these two genes; this may be fairly specific for genes dealing with rifampin inactivation since no other significantly similar sequences were detected in the search with BLASTN. Studies of the organisms from which the respective genes were cloned, M. smegmatis and R. equi, indicate that the genes are inducible in both cases. However, in other related species gene expression is apparently constitutive. The genes from these are being cloned; this may allow for the identification of those features of upstream sequence responsible for regulation. , and 20 g of antibiotic per ml (dots 1 to 3, respectively) and mutant 43756Km1 challenged with 1, 10, and 20 g of antibiotic per ml (dots 4 to 6, respectively). Rifampin added to medium without cells gave zones of the same size as those in dots 4 to 6. Sampling was after 44 h of shaking at 37°C.
